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Qizhong Luo1 and Jiyao Jiang1Abstract
Background: Endoscopic transsphenoidal surgery has gradually come to be regarded as a preferred option in the
treatment of pituitary adenomas because of its advantages of improved visualization and its minimal invasiveness.
The aim of this study was to compare and evaluate the outcomes and complications of endoscopic and
microscopic transsphenoidal surgery in the treatment of pituitary adenomas.
Methods: We performed a systematic literature search of MEDLINE, EMBASE, the Cochrane Library and the Web of
Science between January 1992 and May 2013. Studies with consecutive patients that explicitly and fully compared
endoscopic and microscopic approaches in the treatment of pituitary adenomas were included.
Results: A total of 15 studies (n = 1,014 patients) met the inclusion criteria among 487 studies that involved
endoscopic surgery and 527 studies that dealt with microscopic surgery. The rate of gross tumor removal was
higher in the endoscopic group than in the microscopic group. The post-operative rates of septal perforation
were less frequent in patients who underwent endoscopic surgery. There was no significant difference between
the two techniques in the incidence rates of meningitis, diabetes insipidus, cerebrospinal fluid leak, epistaxis or
hypopituitarism. The post-operative hospital stay was significantly shorter for the endoscopic surgery group
compared with the microscopic surgery group (P < 0.05). There was no significant difference in the length of
the operation (P > 0.05).
Conclusions: The present study indicates that the endoscopic transsphenoidal approach is safer and more
effective than microscopic surgery in the treatment of pituitary adenomas.
Keywords: Meta-analysis, Pituitary adenoma, Endoscopic, Transsphenoidal, MicroscopicBackground
In the late nineteenth century, the resection of a pituit-
ary tumor via an open craniotomy was first described by
Horsley [1]. Since then, the field of pituitary surgery has
undergone constant evolution. Schloffer et al. [2] were
the first to report the transsphenoidal approach in a sella
tumor in 1907. It was Cushing et al. [3] who abandoned
external incisions and popularized the sublabial trans-
septal transsphenoidal technique. In the 1960s, Hardy
[4] perfected Cushing’s approach with the introduction
of the operative microscope. The traditional transseptal/* Correspondence: drchunlongzhong@126.com; renjiwangyu@gmail.com
1Department of Neurosurgery, Renji Hospital, School of Medicine, Shanghai
Jiao Tong University, Shanghai 200127, China
2Department of Obstetrics & Gynecology, Renji Hospital, School of Medicine,
Shanghai Jiao Tong University, Shanghai 200127, China
© 2014 Gao et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the ortranslabial approach has long been considered as the
standard approach because it is associated with minimal
morbidity and mortality. In recent years, with the devel-
opment of endoscopic instruments and techniques,
Jankowski [5] proposed a fully endoscopic approach to
pituitary surgery in 1992. Currently, endoscopic trans-
sphenoidal pituitary surgery has become a preferred al-
ternative option because of its advantages of improved
visualization and minimal invasiveness, which allows
surgeons to gain access to central skull base lesions.
However, the endoscope has the disadvantage of lacking
the stereoscopic view obtainable with a microscope,
which makes the benefits of the two techniques equivo-
cal when comparing them in the treatment of pituitary
adenomas.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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comes and the complications associated with these two
techniques by comparing endoscopic with microscopic
surgery in the treatment of pituitary adenomas through
a meta-analysis of the current relevant literature.
Methods
Search strategy
We performed a systematic search of MEDLINE, EMBASE,
the Cochrane Library and the Web of Science for relevant
literature between January 1992 and May 2013. We identi-
fied all relevant published and unpublished primary studies
via an exhaustive search strategy. The following search
terms were used: ‘pituitary’, ‘pituitary and surgery’, ‘endo-
scopic and pituitary’, ‘endoscopic/endoscopy’, ‘microscopic/
microsurgery’, ‘transsphenoidal and surgery’. We browsed
the abstracts and titles of primary collections and extracted
all observational studies. Potentially relevant articles were
considered by double evaluation. Additionally, the refer-
ences of all obtained studies were reviewed for possible
inclusion. The results were searched for humans and the
English language.
Inclusion/exclusion criteria
Studies were deemed appropriate for inclusion if they
met the following criteria: 1) a direct comparison between
fully endoscopic and microscopic (sublabial, transeptal)
approaches for pituitary adenoma; 2) retrospective studies
that included consecutive patients; and 3) each com-
pared group included 10 or more patients who had
undergone surgery in the same center. The exclusion
criteria were as follows: 1) endoscopic-assisted compari-
son studies, single-armed studies or non-human studies;Figure 1 Flowchart diagram of the study selection process.and 2) non-investigative studies (technical reports, case
series, letters, and comments).
The search results were assessed independently by two
authors (Siyi Xu and Yang Guo). Any disagreement was
resolved unanimously by discussion.
Methodological quality
The quality assessment of the retrospective comparative
study was performed based on the Newcastle-Ottawa
Scale [6], a scale that is also recommended by the
Cochrane Non-Randomized Studies Methods Working
Group. Each study was graded as ‘I’ if the score was >6 or
as ‘II’ if the score was ≦5.
Statistical analysis
Review Manager, version 4.2 (Revman, The Cochrane
Collaboration; Oxford, UK) was used for the meta-
analysis. All outcomes considered in this study were
dichotomous and, therefore, proportions with their cor-
responding 95% confidence interval (CI) are reported.
We chose to use the odds ratio (OR) as the summary
statistic (an OR >1 favors the endoscopic group for gross
tumor removal (GTR), whereas an OR <1 favors the
endoscopic group for observed complications). Tests for
heterogeneity were performed with the Chi-square and
I2 for each meta-analysis. A fixed effects model was used
when no heterogeneity (P > 0.05, I2 = 0%) or minimal
heterogeneity (P > 0.05, I2 < 25%) was present, while a
random effects model was applied in the presence of
high heterogeneity (P < 0.05, I2 > 50%). The length of the
operation and of the hospital stay were analyzed by
using the equal-variance t-test (SPASS 19.0) and were
considered significant if the P value was <0.05. In
Table 1 Characteristics of publication year, study type, cases in each group and GTR, length of operation and hospital







Cases of GTR Length of operation
(mean, min)
Length of hospital stay
(day)
E M E M E M E M
Chen et al. [7] 2011 RC 68 59 48 29 128 170 4.3(3 to 12) 7.3(5 to 22)
D'Haens et al. [8] 2009 RC 60 60 38 30 NA NA NA NA
Higgins et al. [9] 2008 RC 16 25 14 20 117 152 3 5.3
O'Maley et al. [10] 2008 RC 25 25 14(21)a 17(22)a 176.4 264.6 3.92 (3 to 9) 4.84 (3 to 9)
Choe et al. [11] 2008 RC 12 11 10 8 NA NA NA NA
Casler et al. [12] 2005 RC 15 15 10 12 255.33 245.73 4.4(2 to 7) 5.73(3 to 8)
Atkinson et al. [13] 2008 RC 21 21 21 21 NA NA 3.0(1 to 10) 4.5(2 to 9)
Sheehan et al. [14] 1999 RC 26 44 7(16)a 15(36)a 162 204 NA NA
White et al. [15] 2004 RC 50 50 NA NA NA NA 3.7 5.4
Razak et al. [16] 2013 RC 40 40 15(16)a 8(14)a 202 169 6 ± 7.5 8 ± 6.7
Messerer et al. [17] 2011 RC 82 82 61 41 NA NA NA NA
Cappabianca et al. [18] 1999 RC 10 20 9 14 NA NA 3.1 ± 0.4 6.2 ± 0.3
Koren et al. [19] 1999 RC 20 20 NA NA NA NA 3.7(3 to 4) 7(6 to 10)
Duz et al. [20] 2008 RC 28 40 15 20 NA NA NA NA
Neal et al. [21] 2007 RC 14 15 NA NA NA NA 3.4 8.3
aOnly the cases in brackets were followed to evaluate resection rate. E, endoscopic group; GTR, gross tumor removal; M, microscopic group; NA, not available; RC,
retrospective cohort study.
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the summary estimates was tested by both the Harbord-
Egger bias indicator and Begg-Mazumdar bias indicator.
A two-tailed P-value <0.05 was considered statistically








E M E M E
Chen et al. [7] I 1 1 3 2 2
D'Haens et al. [8] I 1 1 6 1 NA
Higgins et al. [9] I 0 0 1 1 5
O'Maley et al. [10] I 0 0 3 1 1
Choe et al. [11] I 0 0 2 2 1
Casler et al. [12] I 0 1 4 3 3
Atkinson et al. [13] I 0 0 3 2 3
Sheehan et al. [14] I 0 0 3 7 1
White et al. [15] I 1 8 6 7 11
Razak et al. [16] I NA NA 4 6 4
Messerer et al. [17] I 4 1 10 7 7
Cappabianca et al. [18] II 0 0 0 0 4
Koren et al. [19] II 0 2 4 5 NA
Duz et al. [20] II 0 0 8 10 NA
Neal et al. [21] II 0 0 4 8 1
CSF, cerebrospinal fluid; DI, diabetes insipidus; NA, not available.Analyzed items
The primary data items for this meta-analysis were: 1) the
GTR, based on either post-operative imaging and/or
normalization of hormonal hypersecretion that confirmed
the absence of any tumor; 2) the length of the hospital staytions for included studies






M E M E M E M
3 0 1 1 2 0 1
NA 1 0 NA NA 1 0
7 NA NA 1 4 1 2
4 0 1 NA NA 0 1
1 0 1 NA NA 1 3
2 NA NA 0 3 NA NA
3 NA NA NA NA NA NA
0 NA NA 0 2 NA NA
11 1 0 0 1 NA NA
11 1 0 NA NA NA NA
8 3 4 NA NA 5 9
2 NA NA NA NA NA NA
NA NA NA 2 6 NA NA
NA NA NA NA NA NA NA
5 NA NA NA NA NA NA
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(post-operative cerebrospinal fluid (CSF) leak, diabetes
insipidus (DI), hypopituitarism, meningitis, epistaxis, septal
perforation).
Results
A total of 2,638 articles were initially identified using our
search strategy and review of bibliographies. These arti-
cles were examined to exclude irrelevant studies, result-
ing in 30 potentially eligible articles. Subsequently, theFigure 2 Forest plot of the odd ratios and 95% CI for GTR and septal
pituitary adenoma surgery. CI, confidence interval; GTR, gross tumor remfull texts of these studies were examined thoroughly, and
19 articles were excluded based on their failure to meet
the inclusion criteria. Four additional records which meet
the inclusion criteria were obtained through a manual
search. Ultimately, 15 articles retrospectively comparing
endoscopic versus microscopic surgery in the treatment
of pituitary adenomas were identified (Figure 1). The
characteristics of the included studies are summarized in
Table 1 and Table 2. All of the included reports were retro-
spective studies published between 1992 and 2013. A totalperforation in patients who had endoscopic and microscopic
oval.
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microscopic group = 527). Unfortunately, large, prospect-
ive, randomized studies comparing the two techniques
were not available because of the lack of relevant reports.
According to the selected criteria of methodological
quality, eleven studies [7-17] were identified as grade ‘I’
and four studies [18-21] were identified as grade ‘II’. To
identify potential sources of the observed heterogeneity
and to test the stability of our results, a sensitivity analysis
was further performed by removing the grade ‘II’ studies.Figure 3 Sensitivity analyses of GTR, epistaxis and septal perforation.Reviewing the characteristics of the surgical proce-
dures of the included studies, O’Maley et al. [10] re-
ported 25 cases separately in each surgery group;
however, only 21 cases in the endoscopic group and 22
cases in the microscopic group were followed to evaluate
the resection rate. Sixteen cases in the endoscopic group
and 36 cases in the microscopic group were followed to
evaluate the resection rate in Sheehan’s study [14], and
16 cases in the endoscopic group and 14 cases in the
microscopic group were followed to evaluate the resectionGTR, gross tumor removal.
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tive time were not available for the meta-analysis because
standard deviations either were not reported by, or could
not be computed for, most of the reports.
We used meta-analytical techniques to obtain pooled
estimates rates of post-operative outcomes and compli-
cations. Reviewing the characteristics of the surgical
procedures, twelve studies [7-14,16-18,20] (endoscopic
group = 365, microscopic group = 405) reported data on
GTR. A fixed effects model was used because there was no
evidence of significant heterogeneity (X2 = 12.11, P = 0.28,
I2 = 17.4%). The proportion of patients with GTR was
significantly different between the endoscopic group andFigure 4 Forest plot of the odd ratios and 95% CI for CSF leak, DI wh
CI, confidence interval; CSF, cerebrospinal fluid; DI, diabetes insipidus.the microscopic group (OR = 1.86, 95% CI 1.36 to 2.54)
(Figure 2.1). A higher rate of GTR was performed in the
endoscopic group than in the microscopic group (71.8%
versus 58.0%). A sensitivity analysis was performed
by removing two studies [18,20], and the outcome of
the analysis revealed a significant difference between the
endoscopic group and the microscopic group, which was
consistent with previous results (OR = 1.93, 95% CI 1.38 to
2.70) (Figure 3.1). The Begg’s Test (P = 0.586) and Egger’s
Test (P = 0.590) showed no publication bias.
Six studies reported on post-operative septal perforation.
The difference between the endoscopic and the micro-
scopic groups was statistically significant (OR = 0.28, 95%o had endoscopic and microscopic pituitary adenoma surgery.
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overall proportions for the endoscopic and microscopic
groups was 2.1% versus 8.5%, respectively. The proportion
of septal perforation was significantly lower in those who
had endoscopic surgery. A sensitivity analysis was per-
formed by removing one study [19], and the outcome of
the analysis revealed a significant difference between the
endoscopic and microscopic groups, which was consistent
with previous results (OR = 0.29, 95% CI 0.09 to 0.96)
(Figure 3.3).
Thirteen studies (endoscopic group = 477, microscopic
group = 507) reported data on CSF leak. A fixed effects
model was used because there was no evidence of sig-
nificant heterogeneity (X2 = 7.88, P = 0.85, I2 = 0%). The
occurrence rate of CSF leak was not significantly differ-
ent between the endoscopic group and the microscopic
group (OR = 1.11, 95% CI 0.75 to 1.63) (Figure 4.1). The
incidence rate of CSF leak in the endoscopic group wasFigure 5 Sensitivity analyses of CSF leak and DI. CSF, cerebrospinal fluinot significantly lower than in the microscopic group
(12.8% versus 12.2%, respectively). A sensitivity analysis
of the CSF leak was performed by removing three stud-
ies [19-21], and the outcome of the analysis did not re-
veal a significant difference between the endoscopic and
the microscopic groups, which was consistent with pre-
vious results (OR = 1.26, 95% CI 0.8 to 2.0) (Figure 5.1).
The Begg’s Test (P = 0.2) and Egger’s Test (P = 0.28) for
CSF leak showed no publication bias.
A fixed effects model was used for DI because there
was no evidence of significant heterogeneity (X2 = 12.43,
P = 0.33, I2 = 11.5%). The occurrence rate of DI was
11.3% in the endoscopic group and 14.0% in the micro-
scopic group. The pooled estimates of the overall pro-
portions showed no significant difference between the
endoscopic and microscopic groups based on the results of
11 studies (OR = 0.81, 95% CI 0.53 to 1.24) (Figure 4.2).
A sensitivity analysis was performed by removing twod; DI, diabetes insipidus.
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reveal a significant difference between the endoscopic
and the microscopic groups, which was consistent
with previous results (OR = 0.78, 95% CI 0.49 to 1.23)
(Figure 5.2). The Begg’s Test (P = 0.89) and Egger’s Test
(P = 0.81) for DI indicated that there was no publication
bias.
Six studies reported data on pituitary hypopituitarism.
A fixed effects model was used because there was noFigure 6 Forest plot of the odd ratios and 95% CI for hypopituitarism
microscopic pituitary adenoma surgery. CI, confidence interval.evidence of significant heterogeneity (X2 = 1.85, P = 0.87,
I2 = 0%). In those studies, we found that the proportion
of pituitary dysfunction was 3% in the endoscopic group
and 6.1% in the microscopic group. The endoscopic ap-
proach appeared to reduce the occurrence rate of hypo-
pituitarism. However, the pooled estimates of the meta-
analysis showed that there was no significant difference
between the two groups for the rate of complications
(OR = 0.53, 95% CI 0.23 to 1.20) (Figure 6.1)., meningitis and epistaxis in patients who had endoscopic and
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A fixed effects model was used because there was no
evidence of significant heterogeneity (X2 = 3.08, P = 0.80,
I2 = 0%). The pooled complication OR for meningitis in-
dicated that the occurrence rate of meningitis was not
significantly different between the endoscopic and the
microscopic groups (OR = 0.88, 95% CI 0.35 to 2.18)
(Figure 6.2).
The proportion of patients with post-operative epi-
staxis was not significantly different between the endo-
scopic group and the microscopic group (OR = 0.51, 95%
CI 0.22 to 1.23) (Figure 6.3). The proportion of epistaxis
was not significantly different between the endoscopic
and the microscopic groups (2.4% versus 4.9%). A sensi-
tivity analysis was performed by removing one study
[19], and the outcome of the analysis revealed no differ-
ence between the endoscopic and microscopic groups,
which was consistent with previous results (OR = 0.58,
95% CI 0.23 to 1.45) (Figure 3.2).
A total of six endoscopic studies reported data on the
length of operation with a mean time of 173 ± 5 minutes
versus 201 ± 46 minutes for the microscopic groups
(Table 3). The difference was not statistically significant
(P = 0.259). However, 10 endoscopic studies reported
data on the hospital stay that showed a mean time of
3.8 ± 0.9 days in the endoscopic group while 6.3 ±
1.3 days in the microscopic group, respectively. The dif-
ference between the two approaches was statistically
significant (P = 0.0002), and the hospital stay was sig-
nificantly shorter in the endoscopic group than in the
microscopic group.
Discussion
Over the last century, pituitary adenoma surgery has
evolved from a craniotomy approach toward less inva-
sive approaches. In the past twenty years, there is grow-
ing evidence to support the use of endoscopic techniques
as an alternative approach in the treatment of pituitaryTable 3 Comparison of the length of operation and












Length of hospital stay
Mean time, days 3.8 ± 0.9 days 6.3 ± 1.3 days P = 0.00017
Total numberof studies 10c(239) 10c(250)
aStatistical analysis performed using equal-variance t-test; bReferences
[7,9-11,14,16]; cReferences [7,9,10,12,13,15,16,18,19,21].adenomas [16,22-26]. Endoscopy can expand the limits
of the surgeons’ performance of transsphenoidal surgery,
improving visualization and removing tumors that they
could not access before. It is likely that its characteristic
of minimal invasiveness explains the positive outcomes
and lower proportion of post-operative complications of
endoscopic procedures in comparison with the micro-
scopic approach.
Several authors have discussed the potential outcomes
of the endoscopic technique. DeKlotz et al. [22] used
a meta-analysis to reveal the superior rate of GTR
(79% versus 65%, P < 0.0001) as well as the lower rates of
CSF leak (5% versus 7%, P < 0.01), septal perforation (0%
versus 5%) and post-operative epistaxis (1% versus 4%,
P < 0.0001) for the endoscopic approach compared with
the sublabial approach. Rotenberg et al. [23] concluded
that the two approaches had similar outcomes (GTR, hor-
monal abnormality resolution) but that the endoscopic ap-
proach was associated with fewer complications as well as
a shorter hospital stay and length of operation. Goudakos
et al. [24] demonstrated that the rates of GTR/CSF leak-
age were similar between the two techniques. However,
the study also revealed a lower incidence of post-operative
DI and a shorter hospital stay in the studied endoscopic
groups. Other systematic reviews also support the safety
and short-term efficacy of endoscopic pituitary surgery
[16,25]. Interestingly, Ammirati et al. [27] recently re-
ported a meta-analysis concluding that endoscopic re-
moval of pituitary adenoma, in the short term, does not
seem to confer any advantages over the microscopic tech-
nique and the incidence of vascular complications was
higher with endoscopic than with microscopic removal of
pituitary adenomas.
How can the reported difference be explained? The
primary explanation is that most of the previous reports
pertain to single-armed studies in the absence of a reli-
able comparison. Second, the inclusion and exclusion
criteria are key factors in each study, which may lead to
different conclusions. In addition, the complication rate
in microscope-based surgery is already low and the rates
of GTR are high. Demonstrating a statistically significant
difference between endoscopic and microscopic tech-
niques will require a larger number of cases. Further-
more, a learning curve [28,29] is anticipated because the
endoscopic approach is a newer technique, and gradual
improvement in outcomes will occur as the cumulative
experience increases over time. Future studies are re-
quired to resolve the learning curve issues.
However, Doglietto et al. [30] reported that it may not
be the time to conduct meta-analyses of endoscopic
skull base surgery but it is certainly an appropriate time
to collected data prospectively. As we know, the devel-
opment of a new surgical technique often begets criti-
cism due to the possibility of a learning curve. To date,
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formed to compare outcomes between endoscopic and
microsurgical transsphenoidal techniques. We believe
that the endoscopic technique, after a first phase of
un-acceptance, will prove its efficacy or superiority to
‘classic’ techniques and a systematic retrospective study
of published results to compare microsurgical and endo-
scopic techniques in the treatment of pituitary adenomas
may provide important significant guidance for further
research.
The results of our meta-analysis clearly favor the
endoscopic approach for pituitary surgery over the
microscopic approach. The endoscopic approach yielded
a significantly improved rate of GTR with lower rate of
post-operative septal perforation and a shorter length of
hospital stay. There were no significant differences be-
tween the two approaches for meningitis, epistaxis, DI,
CSF leak, hypopituitarism and the overall length of oper-
ation time. It is important to recognize that the above
analysis represents only the results of early outcomes
and complications. There are few published long-term
studies following these patients beyond the initial post-
operative period.
The endoscopic technique appears to provide a higher
rate of GTR compared with microscopic resection. The
results from our analysis showed that the rate of GTR
was significantly higher in the endoscopic group than in
the microscopic group (71.8% versus 58.0%). Unfortu-
nately, a subgroup analysis of the GTR based on the size
of the pituitary adenoma was not feasible in our analysis
because of the lack of available data. The actual size of
the tumors was not recorded in most reports. When size
was reported, it was infrequently correlated to actual
surgical outcomes.
The primary complication for the majority of patients
undergoing pituitary surgery is CSF leak. The currently
accepted view is that the success of reconstructive tech-
niques following dissection should be a major determin-
ant of post-operative CSF leak [18]. Endoscopy appears
to have a huge advantage in reconstruction because it
improves visualization. However, in our study, the rate
of post-operative leaks was similar (12.8% versus 12.2% for
the endoscopic and microscopic groups, respectively). The
main reason for this similarity may be that the improved
exposure during endoscopic surgery would encourage the
surgeons to extend the limits of their operation more ag-
gressively, which may offset the minimally invasive nature
of endoscopic resections and increase the rate of post-
operative CSF leak.
It is important to note that there are some potential
limitations to this study. First, only English-language ar-
ticles were considered, which means that some relevant
studies in other languages may have been omitted from
our meta-analysis; this may have introduced a languagebias. In addition, all of the studies in our analysis are
retrospective studies, which are associated with several
methodological issues including selection bias, incom-
plete data, and a lack of standardization in the study
intervention. Unfortunately, large randomized prospect-
ive studies comparing the two techniques are not avail-
able at present. Moreover, publications to date represent
the results of short-term outcomes and complications.
There are few published long-term studies that follow
these patients beyond the initial post-operative period.
Therefore, we expect our conclusions to be interpreted
with caution.
Conclusions
In conclusion, the results of our meta-analysis support the
safety and short-term effectiveness of endoscopic trans-
sphenoidal pituitary adenoma surgery. The endoscopic ap-
proach is associated with a higher rate of GTR, decreased
hospital stay and reduced observed post-operative compli-
cation (septal perforation). Future studies with a long-term
follow-up are required to determine the outcomes and
complications of endoscopic pituitary surgery.
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